Fremont, CA, United States of America

Target Therapeutics, Inc.


USPTO Granted Patents = 211

% Expired Patents = 1.9


Trademarks = 2

Forward Citations = 44,051

Loading Chart...
Loading Chart...

103 inventors (with patents filed for the assignee):

goldMedal Erik T Engelson (50 out of 60 patents)

silverMedal Gene L Samson (48 out of 63 patents)

bronzeMedal Ivan Sepetka (28 out of 112 patents)

4.  Son M Gia (21 out of 44 patents)

5.  Thomas J Palermo (18 out of 54 patents)

6.  Joseph Charles Eder (16 out of 52 patents)

7.  Uriel Hiram Chee (15 out of 18 patents)

8.  Michael J Mariant (15 out of 15 patents)

9.  Michael P Wallace (14 out of 149 patents)

10.  Kim D Nguyen (12 out of 38 patents)

11.  Hong Doan (12 out of 18 patents)

12.  U Hiram Chee (12 out of 24 patents)

13.  David J Kupiecki (11 out of 29 patents)

14.  Nga Thi Van (11 out of 11 patents)

15.  Christopher G Ken (10 out of 13 patents)


Core Competencies:
Catheter
Vaso-Occlusive Coil
Mechanical Clot Treatment
Guidewire
Endovascular
Detachable Implant
Balloon Catheter
Bioactive Coating
Electrolytic Detachment
Aneurysm Closure
Braided Catheter
Flexible Coil

211 patents:

Target Therapeutics, Inc. is a leading biotechnology company specializing in the research and development of targeted therapies for various medical conditions. Our mission is to improve patient outcomes by delivering innovative and effective treatments. With a team of highly skilled scientists and state-of-the-art facilities, we strive to discover novel drug candidates and advance them through rigorous preclinical and clinical testing. At Target Therapeutics, we are committed to revolutionizing healthcare by transforming scientific discoveries into life-changing therapies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

211 Patents

#11 in Fremont, CA

#429 in California

#1,971 in US

#4,032 in the World

Fremont, CA (US)
Fremont, CA, United States of America
Forward Citations = 44,051

103 inventors:

Please report any incorrect information to [email protected]
Loading…